Elixinol Wellness Limited ELLXF

Set alert

Price alert · ELLXF

All alert types
0.01 USD +0.01 +217.39%

At close · Oct 29

0.004 Day range 0.004
0.0023 52-week range 0.0168
YTD
-16.09%
1 year
+78.05%
Open
0.004
Prev close
0.0023
Mkt cap
3.32M
Vol
62
Avg vol
1.92K
EPS
-0.01
P/E
0.00
More statistics
Low
0.004
High
0.004

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ELLXF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-21.19 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.6×
FY 2017: -739×FY 2018: -3159×FY 2019: -11.2×FY 2020: -3.3×FY 2021: -13.9×FY 2022: -5.7×FY 2023: -1.0×FY 2024: -2.7×FY 2025: -0.6×
FY 2017 5y median -2.7× FY 2025
P/S 0.2×
FY 2017: 0.0×FY 2018: 72.6×FY 2019: 29.3×FY 2020: 22.8×FY 2021: 25.4×FY 2022: 8.6×FY 2023: 0.9×FY 2024: 0.3×FY 2025: 0.2×
FY 2017 5y median 0.9× FY 2025
P/B 0.4×
FY 2017: 20.2×FY 2018: 18.8×FY 2019: 8.1×FY 2020: 9.6×FY 2021: 12.4×FY 2022: 6.6×FY 2023: 1.2×FY 2024: 0.5×FY 2025: 0.4×
FY 2017 5y median 1.2× FY 2025
P/FCF -1.0×
FY 2017: -3049×FY 2018: -277×FY 2019: -14.5×FY 2020: -14.9×FY 2021: -16.5×FY 2022: -7.4×FY 2023: -2.8×FY 2024: -1.3×FY 2025: -1.0×
FY 2017 5y median -2.8× FY 2025
EV/EBITDA -1.4×
FY 2017: -732×FY 2018: -6823×FY 2019: -12.5×FY 2020: -14.5×FY 2021: -16.1×FY 2022: -6.4×FY 2023: -1.2×FY 2024: -1.4×FY 2025: -1.4×
FY 2017 5y median -1.4× FY 2025
EV/Sales 0.4×
FY 2017: 0.0×FY 2018: 71.5×FY 2019: 28.8×FY 2020: 21.1×FY 2021: 24.4×FY 2022: 8.4×FY 2023: 1.0×FY 2024: 0.4×FY 2025: 0.4×
FY 2017 5y median 1.0× FY 2025
FCF Yield -98.2%
FY 2017: -0.0%FY 2018: -0.4%FY 2019: -6.9%FY 2020: -6.7%FY 2021: -6.0%FY 2022: -13.5%FY 2023: -36.2%FY 2024: -75.4%FY 2025: -98.2%
FY 2017 5y median -36.2% FY 2025

Profitability

Gross Margin 4.9%
FY 2017: 0.0%FY 2018: 53.7%FY 2019: -2.4%FY 2020: -63.8%FY 2021: -67.0%FY 2022: -46.3%FY 2023: 41.4%FY 2024: 37.7%FY 2025: 4.9%
FY 2017 5y median 4.9% FY 2025
Operating Margin -32.1%
FY 2017: 0.0%FY 2018: -2.6%FY 2019: -84.1%FY 2020: -147.3%FY 2021: -167.2%FY 2022: -141.8%FY 2023: -78.1%FY 2024: -34.1%FY 2025: -32.1%
FY 2017 5y median -78.1% FY 2025
Net Margin -35.5%
FY 2017: 0.0%FY 2018: -2.3%FY 2019: -262.5%FY 2020: -696.2%FY 2021: -182.3%FY 2022: -149.8%FY 2023: -90.8%FY 2024: -11.5%FY 2025: -35.5%
FY 2017 5y median -90.8% FY 2025
ROE -73.8%
FY 2017: -2.7%FY 2018: -0.6%FY 2019: -72.4%FY 2020: -293.1%FY 2021: -89.2%FY 2022: -115.4%FY 2023: -116.2%FY 2024: -17.2%FY 2025: -73.8%
FY 2017 5y median -89.2% FY 2025
ROIC -35.6%
FY 2017: -2.6%FY 2018: -0.7%FY 2019: -20.3%FY 2020: -57.7%FY 2021: -71.4%FY 2022: -90.4%FY 2023: -82.9%FY 2024: -11.2%FY 2025: -35.6%
FY 2017 5y median -71.4% FY 2025
ROA -34.5%
FY 2017: -2.6%FY 2018: -0.6%FY 2019: -66.6%FY 2020: -246.1%FY 2021: -67.2%FY 2022: -78.4%FY 2023: -64.1%FY 2024: -9.3%FY 2025: -34.5%
FY 2017 5y median -64.1% FY 2025

Growth (YoY)

Revenue 3.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -17.3%FY 2020: -51.1%FY 2021: -37.8%FY 2022: -24.4%FY 2023: 17.2%FY 2024: 80.9%FY 2025: 3.6%
FY 2017 FY 2025
Operating Income 2.6%
FY 2017: 0.0%FY 2018: 64.2%FY 2019: -2540.9%FY 2020: 14.4%FY 2021: 29.4%FY 2022: 35.9%FY 2023: 35.4%FY 2024: 21.0%FY 2025: 2.6%
FY 2017 FY 2025
EPS (diluted) -92.8%
FY 2017: 0.0%FY 2018: 63.3%FY 2019: -6207.7%FY 2020: -9.8%FY 2021: 90.6%FY 2022: 38.2%FY 2023: -280.4%FY 2024: 88.8%FY 2025: -92.8%
FY 2017 FY 2025
Free Cash Flow 7.1%
FY 2017: 0.0%FY 2018: -1380.4%FY 2019: -538.7%FY 2020: 63.1%FY 2021: 37.4%FY 2022: 43.2%FY 2023: 66.0%FY 2024: -27.2%FY 2025: 7.1%
FY 2017 FY 2025

Financial Health

Current Ratio 0.9×
FY 2017: 9.5×FY 2018: 7.9×FY 2019: 8.5×FY 2020: 7.1×FY 2021: 4.2×FY 2022: 2.7×FY 2023: 1.6×FY 2024: 1.4×FY 2025: 0.9×
FY 2017 5y median 1.6× FY 2025
Quick Ratio 0.5×
FY 2017: 8.5×FY 2018: 6.9×FY 2019: 5.0×FY 2020: 6.1×FY 2021: 3.7×FY 2022: 2.2×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 0.5×
FY 2017 5y median 0.9× FY 2025
Debt / Equity 0.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.5×
FY 2017 5y median 0.2× FY 2025
Net Debt / EBITDA -0.6×
FY 2017: 6.8×FY 2018: 110×FY 2019: 0.2×FY 2020: 1.1×FY 2021: 0.7×FY 2022: 0.1×FY 2023: -0.1×FY 2024: -0.2×FY 2025: -0.6×
FY 2017 5y median -0.1× FY 2025
Interest Coverage -10.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -194×FY 2020: -451×FY 2021: -170×FY 2022: -141×FY 2023: -64.0×FY 2024: -28.8×FY 2025: -10.2×
FY 2017 5y median -64.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31